Revvity's stock tumbles to lead the S&P 500 losers after earnings miss, lowered outlook
Shares of Revvity Inc. (RVTY) tumbled 14.2% toward a 3 1/2-year low Monday, enough to pace the S&P 500's premarket decliners, after the health sciences company missed third-quarter earnings expectations and cut its full-year outlook citing "increased market uncertainty." The company lowered its guidance ranges for 2023 adjusted earnings per share of $4.53 to $4.57 from $4.70 to $4.90 and for revenue to $2.72 billion to $2.74 billion from $2.80 billion to $2.85 billion. For the third quarter, the company reported net income that fell to $9.5 million, or 8 cents a share, from $85.3 million, or 67 cents a share, in the year-ago period. Excluding nonrecurring items, adjusted EPS of $1.18 came up short of the FactSet consensus of $1.19. Revenue fell 5.8% to $670.7 million to miss the FactSet consensus of $695.4 million. "We executed well during the third quarter in an increasingly challenging end market environment," said Chief Executive Prahlad Singh. The stock, which is on track to open at the lowest price seen since April 2020, has dropped 22.4% over the past three months through Friday while the S&P 500 has shed 10.1%.
-Tomi Kilgore
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
10-30-23 0925ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
What’s Happening in the Markets This Week
-
Worst-Performing Stock ETFs of the Quarter
-
Q3 in Review and Q4 2024 Market Outlook
-
Top-Performing Stock ETFs of the Quarter
-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
5 Stocks to Buy Instead of Overpriced US Equities
-
Consumer Defensives: Despite Angst, Thirsty Investors Have Names to Pursue
-
Industrials: Many Stocks Overvalued After Q3 Outperformance
-
Basic Materials: Despite Index Rise, We See Multiple Long-Term Opportunities
-
What the Election Could Mean for Big Tech Stocks
-
3 Lessons From Recent Stock Market Drama
-
Consumer Cyclicals: Even Amid Moderating Consumer Spending, We See Discounts
-
Healthcare: Valuations Look Fair Overall, With Select Industries Still Undervalued
-
Utilities: Falling Interest Rates, Growth Outlook Boosting Stocks